Details of the Drug Combinations

General Information of This Drug (ID: DMDIOAR)

Drug Name

Treosulfan DMDIOAR

Synonyms

Tresulfan; Dimesyl-meso-erythritol; Erythritol, 1,4-dimethanesulfonate; Erythritol, dimesyl-, meso-; Dihydroxymyleran; Dihydroxybusulfan; 1,4-Di(methanesulfonate)erythritol; NSC 94160; L-Threityl dimesylate; Erythritol, 1,4-bis(methanesulfonate); Threitol-1,4-bismethanesulfonate, meso-; CB 40069; 1,4-Bis(methanesulfonyloxy)-2,3-butanediol; 1,4-Bis(methylsulfonyloxy)threitol; Threitol 1,4-bis(methanesulfonate); ERYTHRITOL, 1,4-DIMETHANESULFONATE, (meso)-; NCGC00181153-01; L-Threitol 1,4-dimethanesulfonate

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Methotrexate + Treosulfan	DC7ZS1W	Methotrexate	Accelerated Phase Chronic Myelogenous Leukemia	[2]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8281).
2	ClinicalTrials.gov (NCT00860574) Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia